| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/14/1997 | EP0772681A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 05/14/1997 | EP0772680A1 A polynucleotide herpes virus vaccine |
| 05/14/1997 | EP0772679A1 Schistosoma protein and uses thereof |
| 05/14/1997 | EP0772632A2 T cell stimulating protein of pestivirus |
| 05/14/1997 | EP0772629A1 T cell epitopes of rye grass pollen allergen |
| 05/14/1997 | EP0772626A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772453A1 In ovo immunization of avian embryos with oil-emulsion vaccines |
| 05/14/1997 | EP0772449A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 05/14/1997 | EP0772437A1 Compositions and methods for delivery of genetic material |
| 05/14/1997 | EP0686041B1 The use of anti-helminth vaccines in the control of parasite disease associated with loss of natural immunity |
| 05/14/1997 | EP0677111B1 Novel proteinaceous particles |
| 05/14/1997 | EP0644894B1 Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus |
| 05/14/1997 | EP0640145B1 Measurement of an enzyme marker as an aid to diagnosis |
| 05/14/1997 | EP0615453B1 Anti-cancer immunotherapeutic vector constructs |
| 05/14/1997 | CN1149889A Isolated nucleic acid molecule with codes for tumor rejection antigen precursor and uses thereof |
| 05/14/1997 | CN1149888A 流感疫苗 Influenza vaccination |
| 05/14/1997 | CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production |
| 05/14/1997 | CN1149875A Quillaja saponin adjuvant and vaccine formulation containing same |
| 05/14/1997 | CN1149835A Group A streptococcal polysaccharide immunogenic compositions and methods |
| 05/13/1997 | US5629414 Dna molecule coding for surface antigen of toxoplama gondii, vaccines |
| 05/13/1997 | US5629408 Immunochemical isolation of in vivo advanced glycosylation endproducts |
| 05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
| 05/13/1997 | US5629194 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
| 05/13/1997 | US5629167 Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay |
| 05/13/1997 | US5629166 Cancer diagnosis |
| 05/13/1997 | US5629165 Calpastatins, detection of neurodegenerative conditions such as alzheimer*s disease by reaction with antibody |
| 05/13/1997 | US5629161 Use of human papillomavirus gene derived peptides for diagnosis |
| 05/13/1997 | US5629146 Method for detection of human papillomavirus (HPV) for diagnostic purposes |
| 05/13/1997 | US5629020 Delivery of sensitive agents such as bioactive peptides |
| 05/13/1997 | US5629001 Oral administration of therapeutic proteins for treatment of infectious disease |
| 05/13/1997 | US5628998 Method for improving amoxicillin absorption in mammals by administering the amoxicillin to the mammal in combination with Rosa roxburghii, Artemisiae argyi folium and/or Brassica oleracea var. capitata L. |
| 05/13/1997 | US5628996 Method for inhibiting the viability of Pseudomonas aeruginosa with cross-reactive and cross-protective monoclonal antibodies |
| 05/09/1997 | WO1997016549A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | WO1997016548A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
| 05/09/1997 | WO1997016542A1 Diagnostics and treatments of periodontal disease |
| 05/09/1997 | WO1997016532A1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 05/09/1997 | WO1997016531A1 Immunity against pasteurella haemolytica leukotoxin |
| 05/09/1997 | WO1997016221A2 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | WO1997016209A1 Expression of cyclin g1 in tumors |
| 05/09/1997 | WO1997016208A1 Influenza vaccine compositions |
| 05/09/1997 | WO1997016207A1 Peptide expression and delivery system |
| 05/09/1997 | WO1997016206A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | WO1997016204A1 Continuous low-dose cytokine infusion therapy |
| 05/09/1997 | WO1997003186A3 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 05/09/1997 | CA2236419A1 Neurogenic differentiation (neurod) genes and proteins |
| 05/09/1997 | CA2236297A1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | CA2234102A1 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | CA2209314A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/08/1997 | CA2499302A1 Dna-based vaccination of fish by immersion |
| 05/07/1997 | EP0771358A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
| 05/07/1997 | EP0771355A1 A method for large scale plasmid purification |
| 05/07/1997 | EP0771352A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 05/07/1997 | EP0771351A1 Surface protein of staphylococcus aureus |
| 05/07/1997 | EP0771327A1 Contraceptive vaccine |
| 05/07/1997 | EP0771326A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 05/07/1997 | EP0771325A1 Process for modifying the stability of antibodies |
| 05/07/1997 | EP0771322A1 Abundant extracellular products and methods for their production and use |
| 05/07/1997 | EP0771320A1 Polynucleotide decoys that ihnibit mhc-ii expression and uses thereof |
| 05/07/1997 | EP0771216A1 Methods and compositions for the specific coagulation of vasculature |
| 05/07/1997 | EP0771215A1 Retroviral transduction of cells using soluble complement inhibitors |
| 05/07/1997 | EP0771214A1 Treatment and prevention of helicobacter infection |
| 05/07/1997 | EP0771213A1 Haemophilus adherence and penetration proteins |
| 05/07/1997 | EP0771212A1 Contraceptive vaccine |
| 05/07/1997 | EP0771208A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 05/07/1997 | EP0771192A1 Use of anti-vegf agents in the treatment of endometriosis |
| 05/07/1997 | EP0771147A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/07/1997 | EP0661993B1 Protection against liver damage by hgf |
| 05/07/1997 | EP0652957B1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/07/1997 | EP0602050B1 Method of stimulating immune response |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | EP0532716B1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 05/07/1997 | CN1149299A Anti-GP39 antibodies and uses therefor |
| 05/07/1997 | CN1149258A Inhibin compositions and methods of use thereof |
| 05/07/1997 | CN1149257A Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/06/1997 | USRE35500 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/06/1997 | US5627067 Monoclonal antibodies cross-reactive and cross-protective against human monoclonal antibodies against pseudomonas aeruginosa serotypes |
| 05/06/1997 | US5627050 Bone-related sulfatase-like protein and process for its production |
| 05/06/1997 | US5627043 Production of proteins with dibasic amino acids and cleavage |
| 05/06/1997 | US5626862 Drug delivery from polymer matrices by release from matrix by degradation of polymer |
| 05/06/1997 | US5626851 Rotavirus reassortant vaccine |
| 05/06/1997 | US5626850 Non-shedding live herpesvirus vaccine |
| 05/06/1997 | US5626846 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 05/06/1997 | US5626843 Treatment of autoimmune diseases, including AIDS, by removel of interferons, TNFs and receptors therefor |
| 05/02/1997 | EP0770874A2 Receptor membranes and ionophore gating |
| 05/02/1997 | EP0770681A2 T cell epitopes of the major allergens from ambrosia artemisiifolia |
| 05/02/1997 | EP0770680A2 Lymphocyte-associated cell surface protein |
| 05/02/1997 | EP0770679A2 HCV-specific peptides, preparations related to them and their use |
| 05/02/1997 | EP0770677A2 Improved sustainable chicken cell line for the production of Marek's disease vaccines |
| 05/02/1997 | EP0770624A2 Peptide capable of inducing immune response to human gastric cancer and agent containing it for preventing or treating human gastric cancer |
| 05/02/1997 | EP0770397A1 Newcastle disease virus combination vaccine |
| 05/02/1997 | EP0770396A2 Use of new factor VIII coagulant polypeptides |
| 05/02/1997 | EP0770394A2 Plant extract composition for bovine mastitis treatment |
| 05/02/1997 | EP0770140A1 Nucleic acid containing composition, preparation and uses of same |
| 05/02/1997 | EP0770138A2 Mycobacteria functional screening and/or expression vectors |
| 05/02/1997 | EP0770135A1 Novel compounds |
| 05/02/1997 | EP0770131A1 Immunodominant polypeptides |
| 05/02/1997 | EP0770092A1 $i(HELICOBACTER PYLORI) NICKEL BINDING PROTEIN |
| 05/02/1997 | EP0770089A1 Growth differentiation factor-12 |
| 05/02/1997 | EP0770086A1 Macrophage migration inhibitory factor-3 |